V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003110 | 280002350 | 1.77 | 107 | Neo-adjuvant (N) | 2016-06-01 | 2016-07-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 280024997 | CISPLATIN + FLUOROURACIL |
| 280003111 | 280002351 | 1.8 | 45.9 | Neo-adjuvant (N) | 2015-12-03 | 2015-12-16 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025000 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003112 | 280002352 | null | null | Adjuvant (A) | null | 2014-12-16 | DOXORUBICIN + IFOSFAMIDE | N | null | 280025002 | DOXORUBICIN + IFOSFAMIDE |
| 280003113 | 280002352 | 1.76 | 60.6 | Neo-adjuvant (N) | 2016-05-09 | 2016-06-21 | Doxorubicin + Ifosfamide | 02 | N | 280025002 | DOXORUBICIN + IFOSFAMIDE |
| 280003114 | 280002353 | 1.64 | 73 | Curative (C) | 2017-02-08 | 2017-04-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025005 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003115 | 280007237 | null | null | null | 2014-09-10 | 2014-09-10 | Doxorubicin + Ifosfamide | N | N | 280025007 | DOXORUBICIN + IFOSFAMIDE |
| 280003116 | 280002354 | null | null | Palliative (P) | 2015-11-12 | 2015-11-23 | DOXORUBICIN + IFOSFAMIDE | 99 | N | 280025008 | DOXORUBICIN + IFOSFAMIDE |
| 280003117 | 280002354 | 1.58 | 82.3 | Curative (C) | 2017-02-20 | 2017-03-07 | CETUXIMAB + RT | 02 | Y | 280025008 | CETUXIMAB + RT |
| 280003118 | 280002354 | null | null | Palliative (P) | null | 2015-06-05 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025008 | DOXORUBICIN + IFOSFAMIDE |
| 280003119 | 280002355 | 1.7 | 74.3 | null | 2015-11-26 | 2015-12-06 | Cisplatin +Fluorouracil (3 wk) | 2 | null | 280025015 | CISPLATIN + FLUOROURACIL |
| 280003120 | 280002356 | 1.68 | 81 | Neo-adjuvant (N) | 2016-12-04 | 2016-12-29 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025018 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003121 | 280002356 | 1.51 | 111 | Curative (C) | 2014-06-27 | 2014-06-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025018 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003122 | 280002357 | null | null | null | 2015-10-10 | 2015-10-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025025 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003123 | 280002358 | 1.73 | null | Neo-adjuvant (N) | 2013-04-05 | 2013-04-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025027 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003124 | 280002359 | 1.63 | 93.6 | Neo-adjuvant (N) | null | 2017-03-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025032 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003125 | 280002360 | 1.64 | 72 | Neo-adjuvant (N) | 2013-03-28 | 2013-04-10 | Doxorubicin + Ifosfamide | 2 | N | 280025033 | DOXORUBICIN + IFOSFAMIDE |
| 280003126 | 280002361 | 1.73 | 65.6 | Curative (C) | 2016-02-13 | 2016-02-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025034 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003127 | 280002362 | 1.77 | 99.8 | Curative (C) | 2014-10-14 | 2014-10-27 | CETUXIMAB + RT | N | N | 280025035 | CETUXIMAB + RT |
| 280003128 | 280002363 | 1.8 | 96.7 | Curative (C) | null | 2014-04-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025036 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003129 | 280002364 | 1.8 | 66.1 | Palliative (P) | 2016-05-05 | 2016-05-13 | DOXORUBICIN + IFOSFAMIDE | 02 | null | 280025037 | DOXORUBICIN + IFOSFAMIDE |
| 280003130 | 280002365 | 1.59 | 93.4 | Palliative (P) | 2014-10-09 | 2014-10-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025039 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003131 | 280002366 | 1.95 | 87.3 | Curative (C) | 2014-03-01 | 2014-03-07 | Cetuximab + Radiotherapy Load | N | Y | 280025040 | CETUXIMAB + RT |
| 280003132 | 280007240 | 1.72 | null | Palliative (P) | 2017-04-16 | 2017-04-20 | Doxorubicin + Ifosfamide | N | N | 280025041 | DOXORUBICIN + IFOSFAMIDE |
| 280003133 | 280007240 | 1.73 | 63.1 | Palliative (P) | 2013-04-19 | 2013-04-20 | Doxorubicin + Ifosfamide | 2 | N | 280025041 | DOXORUBICIN + IFOSFAMIDE |
| 280003134 | 280007240 | 1.86 | 69.9 | Palliative (P) | 2016-05-12 | 2016-05-12 | Doxorubicin + Ifosfamide | N | N | 280025041 | DOXORUBICIN + IFOSFAMIDE |
| 280003135 | 280002367 | 1.82 | 77.7 | Palliative (P) | 2017-12-20 | 2018-01-02 | Doxorubicin + Ifosfamide | 2 | N | 280025046 | DOXORUBICIN + IFOSFAMIDE |
| 280003136 | 280002368 | 1.8 | 86.6 | null | 2017-06-03 | 2017-06-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025049 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003137 | 280002368 | 1.64 | 74 | null | null | 2017-08-20 | Doxorubicin + Ifosfamide | null | null | 280025049 | DOXORUBICIN + IFOSFAMIDE |
| 280003138 | 280002369 | 1.55 | 80.5 | Curative (C) | 2016-06-27 | 2016-07-14 | CETUXIMAB + RT | N | Y | 280025052 | CETUXIMAB + RT |
| 280003139 | 280002370 | 1.65 | 82.6 | null | 2017-02-17 | 2017-02-22 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025054 | DOXORUBICIN + IFOSFAMIDE |
| 280003140 | 280002371 | 1.55 | 81.9 | Palliative (P) | 2016-03-13 | 2016-03-28 | Doxorubicin + Ifosfamide | 02 | N | 280025058 | DOXORUBICIN + IFOSFAMIDE |
| 280003141 | 280002371 | 1.69 | null | Neo-adjuvant (N) | 2015-04-24 | 2015-05-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025058 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003142 | 280002371 | 1.6 | 89.4 | Curative (C) | 2016-10-10 | 2016-11-10 | CETUXIMAB + RT | N | Y | 280025058 | CETUXIMAB + RT |
| 280003143 | 280002371 | 1.76 | 63 | Neo-adjuvant (N) | 2015-04-21 | 2015-04-28 | Doxorubicin + Ifosfamide | 02 | null | 280025058 | DOXORUBICIN + IFOSFAMIDE |
| 280003144 | 280002372 | 1.61 | 79.7 | Curative (C) | 2017-04-19 | 2017-04-22 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025067 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003145 | 280002372 | 1.58 | 87.6 | null | 2016-08-20 | 2016-09-11 | Cisplatin +Fluorouracil (3 wk) | N | N | 280025067 | CISPLATIN + FLUOROURACIL |
| 280003146 | 280002373 | 1.78 | 85.2 | Curative (C) | 2016-03-03 | 2016-03-23 | CETUXIMAB + RT | N | Y | 280025071 | CETUXIMAB + RT |
| 280003147 | 280002374 | 1.76 | 59.4 | Neo-adjuvant (N) | 2017-04-21 | 2017-04-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025072 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003148 | 280002375 | 1.61 | 91 | Curative (C) | 2014-11-26 | 2014-11-26 | Cetuximab + Radiotherapy Load | N | Y | 280025073 | CETUXIMAB + RT |
| 280003149 | 280002376 | 1.65 | 47 | Neo-adjuvant (N) | 2016-12-05 | 2016-12-05 | CISPLATIN + FLUOROURACIL | 2 | null | 280025075 | CISPLATIN + FLUOROURACIL |
| 280003150 | 280002377 | 1.65 | 64.2 | Neo-adjuvant (N) | 2014-06-28 | 2014-07-11 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025076 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003151 | 280002378 | 1.66 | 86 | Curative (C) | null | 2015-09-11 | CETUXIMAB + RT | N | N | 280025078 | CETUXIMAB + RT |
| 280003152 | 280002379 | 1.58 | 82 | Neo-adjuvant (N) | null | 2016-08-30 | Doxorubicin + Ifosfamide | N | N | 280025079 | DOXORUBICIN + IFOSFAMIDE |
| 280003153 | 280002380 | 1.67 | 59.6 | Neo-adjuvant (N) | 2014-02-04 | 2014-02-24 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025083 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003154 | 280002381 | 1.89 | 54.5 | Curative (C) | 2014-03-11 | 2014-03-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280025084 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003155 | 280002382 | 1.55 | 44.5 | Neo-adjuvant (N) | 2014-05-07 | 2014-05-14 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025087 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003156 | 280002383 | 1.75 | 78.9 | null | 2016-12-14 | 2017-01-01 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280025088 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003157 | 280002384 | 1.69 | 71.4 | Curative (C) | 2014-08-15 | 2014-08-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025090 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003158 | 280002384 | 1.56 | null | Curative (C) | 2013-10-21 | 2013-11-04 | CETUXIMAB + RT | null | Y | 280025090 | CETUXIMAB + RT |
| 280003159 | 280002385 | null | null | null | null | 2015-06-11 | CISPLATIN + FLUOROURACIL | N | N | 280025092 | CISPLATIN + FLUOROURACIL |